Armistice Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
+29,964
| New | +$12.1M | 0.21% | 56 |
|
|
2025
Q1 | – | Sell |
-20,044
| Closed | -$10.4M | – | 281 |
|
|
2024
Q4 | $10.4M | Sell |
20,044
-12,109
| -38% | -$6.3M | 0.14% | 89 |
|
|
2024
Q3 | $19.9M | Sell |
32,153
-24,005
| -43% | -$14.8M | 0.32% | 62 |
|
|
2024
Q2 | $31.1M | Buy |
56,158
+41,182
| +275% | +$22.8M | 0.39% | 44 |
|
|
2024
Q1 | $8.7M | Buy |
+14,976
| New | +$8.7M | 0.12% | 100 |
|
|
2023
Q4 | – | Sell |
-21,000
| Closed | -$10.6M | – | 353 |
|
|
2023
Q3 | $10.6M | Sell |
21,000
-24,000
| -53% | -$12.1M | 0.16% | 80 |
|
|
2023
Q2 | $23.5M | Buy |
45,000
+3,000
| +7% | +$1.57M | 0.34% | 52 |
|
|
2023
Q1 | $24.2M | Buy |
42,000
+14,000
| +50% | +$8.07M | 0.35% | 49 |
|
|
2022
Q4 | $15.4M | Sell |
28,000
-22,000
| -44% | -$12.1M | 0.27% | 59 |
|
|
2022
Q3 | $25.4M | Sell |
50,000
-14,000
| -22% | -$7.1M | 0.44% | 48 |
|
|
2022
Q2 | $34.8K | Buy |
64,000
+19,000
| +42% | +$10.3K | 0.61% | 43 |
|
|
2022
Q1 | $26.6M | Buy |
45,000
+21,000
| +88% | +$12.4M | 0.51% | 47 |
|
|
2021
Q4 | $16M | Sell |
24,000
-36,000
| -60% | -$24M | 0.26% | 80 |
|
|
2021
Q3 | $34.3M | Sell |
60,000
-15,000
| -20% | -$8.57M | 0.58% | 47 |
|
|
2021
Q2 | $37.8M | Buy |
75,000
+17,000
| +29% | +$8.58M | 0.68% | 40 |
|
|
2021
Q1 | $26.5M | Buy |
58,000
+19,000
| +49% | +$8.67M | 0.61% | 43 |
|
|
2020
Q4 | $18.2M | Buy |
39,000
+23,000
| +144% | +$10.7M | 0.62% | 47 |
|
|
2020
Q3 | $7.06M | Sell |
16,000
-8,000
| -33% | -$3.53M | 0.26% | 68 |
|
|
2020
Q2 | $8.7M | Sell |
24,000
-4,000
| -14% | -$1.45M | 0.38% | 63 |
|
|
2020
Q1 | $7.94M | Buy |
+28,000
| New | +$7.94M | 0.49% | 54 |
|